WMSA
MRNA icon

Weiss Multi-Strategy Advisers’s Moderna MRNA Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-30,000
Closed -$2.98M – 298
2023
Q4 		$2.98M Buy
+30,000
New +$2.52M 0.07% 314
2020
Q3 		– Sell
-15,300
Closed -$982K – 638
2020
Q2 		$982K Buy
+15,300
New +$838K 0.03% 409

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Weiss Multi-Strategy Advisers's MRNA Position: Q3 2023 in Review

Weiss Multi-Strategy Advisers sold out of Moderna (MRNA) in Q3 2023, closing a stake of 6,799 shares — an estimated $826K sold.

Weiss Multi-Strategy Advisers first reported a position in MRNA in Q4 2018 and held it in 4 quarters. The position peaked at $6.1M in Q2 2021. 889 funds tracked by Wall St. Rank hold MRNA as of Q3 2023.

  • Weiss Multi-Strategy Advisers reported no remaining Moderna position as of Q3 2023 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 6,799 Moderna shares in Q3 2023, an estimated $826K.
  • Weiss Multi-Strategy Advisers first reported a position in Moderna in Q4 2018 and held it in 4 quarters.
  • Weiss Multi-Strategy Advisers's Moderna position peaked at $6.1M in Q2 2021.
  • 889 funds tracked by Wall St. Rank held Moderna as of Q3 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q3 2023, filed 14 Nov 2023.